KDELR3 Is a Prognostic Biomarker Related to the Immune Infiltration and Chemoresistance of Anticancer Drugs in Uveal Melanoma

Figure 5

The differential expression of immune checkpoint molecules in TCGA cohorts between the high-risk group and the low-risk group.